C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
In ovarian cancer, the mechanism of chemoresistance is a key question. Here, the authors demonstrate that C/EBPβ and DOT1L together increase methylation of H3K79, which upregulates expression of oncogenic genes and drives poor platinum response and poor survival in ovarian cancer.
Enregistré dans:
Auteurs principaux: | Dan Liu, Xiao-Xue Zhang, Meng-Chen Li, Can-Hui Cao, Dong-Yi Wan, Bi-Xin Xi, Jia-Hong Tan, Ji Wang, Zong-Yuan Yang, Xin-Xia Feng, Fei Ye, Gang Chen, Peng Wu, Ling Xi, Hui Wang, Jian-Feng Zhou, Zuo-Hua Feng, Ding Ma, Qing-Lei Gao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c9b30596b94249a2a0f1f7ff2dd6da2e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Platinum–copper single atom alloy catalysts with high performance towards glycerol hydrogenolysis
par: Xi Zhang, et autres
Publié: (2019) -
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
par: Laura Godfrey, et autres
Publié: (2019) -
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
par: You Jiang, et autres
Publié: (2021) -
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
par: Rong Liu, et autres
Publié: (2017) -
Evidence that ubiquitylated H2B corrals hDot1L on the nucleosomal surface to induce H3K79 methylation
par: Linjiao Zhou, et autres
Publié: (2016)